Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Sept 2026 for Definium Therapeutics, Inc., €109k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Brandi Roberts: trading record in brief
Brandi Roberts discloses dealings in Definium Therapeutics, Inc. to SEC (Form 4). Between 25 June 2026 and 25 September 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 25 September 2026: a transaction of €109k, in Definium Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brandi Roberts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
3,377 shares@ US$36.73CommonSEC144:0001950047-26-009817
3,013 shares@ US$42.13100.0% of flowCommonSEC144:0001950047-26-006491
2 of 2 declarations
